Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages
(Q73383699)
scientific article published on 01 January 2000
scientific article published on 01 January 2000
Language: